DENTSPLY SIRONA (XRAY)
NASDAQ:XRAY
Want to see XRAY full AI Analyst Report?
XRAY Stock Chart & Stats
$12.51
-$0.04(-0.21%)
At close: 4:00 PM EST
$12.51
-$0.04(-0.21%)
Day’s Range― - ―
52-Week Range$9.41 - $17.09
Previous CloseN/A
Volume461.38K
Average Volume (3M)4.97M
Market Cap
$2.00B
Enterprise Value$4.20B
Total Cash (Recent Filing)$190.00M
Total Debt (Recent Filing)$2.33B
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Jul 30, 2026EPS Estimate
0.36Next Dividend Ex-DateN/A
Dividend Yield5.61%
Share Statistics
EPS (TTM)-3.15
Shares Outstanding200,326,680
10 Day Avg. Volume6,000,079
30 Day Avg. Volume4,973,997
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)1.70
Price to Sales (P/S)0.62
P/FCF Ratio21.91
Enterprise Value/Market Cap2.10
Enterprise Value/Revenue1.14
Enterprise Value/Gross Profit2.33
Enterprise Value/Ebitda-33.09
Forecast
1Y Price Target
$13.95Price Target Upside11.51% Upside
Rating ConsensusHold
Number of Analyst Covering12
EPS Forecast (FY)1.42
Revenue Forecast (FY)$3.58B
Bulls Say, Bears Say
Bulls Say
Capital Allocation And BuybacksManagement eliminated the dividend and plans to redeploy cash toward debt reduction and share repurchases, increasing financial flexibility to support operational stabilization and potential shareholder value recovery.
Earnings CadenceAnalyst adjusted the financial model to align with management comments on the expected pattern of earnings per share, creating clearer expectations for the company's earnings cadence.
Revenue And Segment PerformanceRevenue and all major business segments exceeded analyst expectations, indicating broad operational improvement and stronger demand across core markets.
Bears Say
Interest Expense PressureAnalyst revised interest expense assumptions upward, which raises projected financing costs and can reduce net earnings.
Leverage And Financial RiskElevated leverage increases financial risk and may limit the company's ability to invest in growth initiatives or respond to adverse events.
Mixed Results And Uncertain MomentumReported results and guidance were mixed, creating uncertainty about near-term financial momentum and prompting analysts to seek more tangible progress before upgrading recommendations.
DENTSPLY SIRONA News
XRAY FAQ
What was DENTSPLY SIRONA’s price range in the past 12 months?
DENTSPLY SIRONA lowest stock price was $9.40 and its highest was $17.09 in the past 12 months.
What is DENTSPLY SIRONA’s market cap?
DENTSPLY SIRONA’s market cap is $2.00B.
When is DENTSPLY SIRONA’s upcoming earnings report date?
DENTSPLY SIRONA’s upcoming earnings report date is Jul 30, 2026 which is in 61 days.
How were DENTSPLY SIRONA’s earnings last quarter?
DENTSPLY SIRONA released its earnings results on May 05, 2026. The company reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.278 by -$0.008.
Is DENTSPLY SIRONA overvalued?
According to Wall Street analysts DENTSPLY SIRONA’s price is currently Undervalued.
Does DENTSPLY SIRONA pay dividends?
DENTSPLY SIRONA pays a Quarterly dividend of $0.16 which represents an annual dividend yield of 5.61%. See more information on DENTSPLY SIRONA dividends here
What is DENTSPLY SIRONA’s EPS estimate?
DENTSPLY SIRONA’s EPS estimate is 0.36.
How many shares outstanding does DENTSPLY SIRONA have?
DENTSPLY SIRONA has 200,326,680 shares outstanding.
What happened to DENTSPLY SIRONA’s price movement after its last earnings report?
DENTSPLY SIRONA reported an EPS of $0.27 in its last earnings report, missing expectations of $0.278. Following the earnings report the stock price went down -2.023%.
Which hedge fund is a major shareholder of DENTSPLY SIRONA?
Currently, no hedge funds are holding shares in XRAY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DENTSPLY SIRONA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$13.95 (11.51% Upside)
$13.95 (11.51% Upside)
Blogger Sentiment
Bullish
XRAY Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 2.9M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.4%
Last 30 Days ▼ 0.9%
Last 30 Days ▼ 0.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.29%
12-Months-Change
Fundamentals
Return on Equity
-41.21%
Trailing 12-Months
Asset Growth
-13.57%
Trailing 12-Months
Company Description
DENTSPLY SIRONA
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
XRAY Company Deck
XRAY Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced mix of encouraging operational and financial actions alongside notable near-term challenges. Positives include improved operating cash flow, active deleveraging (≈$79–$80M debt retired), early cost savings (≈$20M OpEx reduction in Q1) and meaningful innovation launches (AI diagnostic aid with ~46% sensitivity improvement, dental MRI clearance, new endodontic tools). Management also maintained full-year guidance and highlighted distributor expansion and early commercial traction. Offsetting these are material constant-currency revenue declines (Q1 cc sales down 6.7%, down 4.5% excluding one-time items), significant margin compression (adjusted EBITDA down 430 bps; gross profit down 560 bps), softness in several key segments (OIS, EDS, IPS, CTS), tariff-related margin pressure, distributor destocking, and an expected ~$30M inventory sell-through headwind later in the year. Given the roughly balanced set of meaningful positives (cash, cost saves, innovation, distribution) and negatives (sales declines, margin pressure, macro/timing risks), the overall tone is cautiously constructive but realistic about near-term headwinds.View all XRAY earnings summariesXRAY Net sales Breakdown
15.71% Equipment & Instruments
12.45% CAD/CAM
39.92% Essential Dental Solutions
6.17% Orthodontics
16.93% Implants & Prosthetics
8.83% Wellspect Healthcare
XRAY Stock 12 Month Forecast
Average Price Target
$13.95
▲(11.51% Upside)
Technical Analysis
Ownership Overview
0.66% Insiders
33.23% Mutual Funds
45.39% Other Institutional Investors
1.45% Public Companies and
Individual Investors